This inventor holds 3 USPTO granted patents. Top assignee: University of Michigan. Active years: 2008-2010.
Company Filing History:
Years Active: 2008-2010
Title: Innovations of Jiangyong Chen
Introduction
Jiangyong Chen is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biochemistry and molecular biology through his innovative research and inventions. With a total of 3 patents, his work focuses on developing small molecules that have the potential to impact cancer treatment.
Latest Patents
One of Jiangyong Chen's latest patents is titled "Indole inhibitors of MDM2 and the uses thereof." This invention relates to small molecules that function as inhibitors of the interaction between p53 and MDM2. The compounds developed through this research are intended for use in inhibiting cell growth, inducing cell death, and sensitizing cells to additional agents. Another notable patent is "Gossypol co-crystals and the use thereof." This invention involves compositions comprising co-crystals of (−)-gossypol with a carboxylic acid or sulfonic acid, which are useful as inhibitors of Bcl-2 family proteins. The applications of these co-crystals include inducing apoptosis in cells and enhancing the effectiveness of apoptotic cell death.
Career Highlights
Jiangyong Chen is affiliated with the University of Michigan, where he conducts his research and develops his inventions. His work has garnered attention in the scientific community for its potential applications in cancer therapy and cell biology.
Collaborations
Some of Jiangyong Chen's notable coworkers include Shaomeng Wang and Dongguang Qin. Their collaborative efforts contribute to the advancement of research in their respective fields.
Conclusion
Jiangyong Chen's innovative work and patents reflect his commitment to advancing scientific knowledge and developing new therapeutic strategies. His contributions are poised to make a significant impact in the realm of cancer treatment and beyond.